Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015

Go back to Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015
Amgen Inc (NASDAQ: AMGN) Delayed: 347.01 --0 (-0%)
Previous Close $347.01    52 Week High $176.85 
Open $347.01    52 Week Low $133.64 
Day High $347.01    P/E 52.26 
Day Low $347.01    EPS $6.64 
Volume 1,279